SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses
Authors:
- 18 January 2023
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 384, 104674
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responsesJournal of Experimental Medicine, 2011
- IAP inhibitors enhance co-stimulation to promote tumor immunityJournal of Experimental Medicine, 2010
- Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent mannerCell Death & Differentiation, 2010
- Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected womenJournal of Immunological Methods, 2010
- TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced ApoptosisJournal of Biological Chemistry, 2009
- Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signalingNature Immunology, 2008
- Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIKNature Immunology, 2008
- c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB ActivationJournal of Biological Chemistry, 2008
- Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activationProceedings of the National Academy of Sciences, 2008
- A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell DeathScience, 2004